WHO IRIS >

Browsing by Subject Pharmaceutical Preparations

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters: 
  Restrict to items in
 
Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 20 of 1158
 next >
Issue DateTitleAuthor(s)Document no.
1991Accès aux médicaments et financement : analyse économique et financière de base / Jérôme Dumoulin, Miloud Kaddar, Germán VelásquezDumoulin, Jérôme; Kaddar, Miloud; Velásquez, Germán; World Health Organization. Action Programme on Essential Drugs and VaccinesWHO/DAP/91.5. Unpublished
1991Acceso a los medicamentos y financiación : análisis económico y financiero de base / Jérôme Dumoulin, Miloud Kaddar, Germán VelasquezDumoulin, Jérôme; Kaddar, Miloud; Velásquez, Germán; World Health Organization. Action Programme on Essential Drugs and VaccinesWHO/DAP/91.5. Unpublished
1991Access to drugs and finance : basic economic and financial analysis / Jérôme Dumoulin, Miloud Kaddar, Germán VelásquezDumoulin, Jérôme; Kaddar, Miloud; Velásquez, Germán; World Health Organization. Action Programme on Essential Drugs and VaccinesWHO/DAP/91.5. Unpublished
1999Access to medicines : an urgent need for solutions : general policy issues / David EarnshawEarnshaw, David-
1999Action Programme on Essential Drugs : interim report of the biennium 1998-1999 : February 1999WHO Action Programme on Essential DrugsWHO/HTP/EDM/MAC(11)/99.4
1989Address to ninth general assembly of the World Federation of Proprietary Medicines Manufacturers / Hiroshi NakajimaNakajima, Hiroshi-
1997Administración de medicamentos y comportamiento de los agentes de salud [carta] / W. K. Asenso-Okyere ... [et al.]Asenso-Okyere, W. K; Osei-Akoto, Isaac; Anum, Adote; Adukonu, Augustina-
1984Adverse reaction terminology, 30 June 1984International Monitoring of Adverse Reactions to Drugs; World Health Organization. Pharmaceuticals Unit; WHO Collaborating Centre for International Drug MonitoringDEM/NC/84.153. Unpublished
1989La Alergia a los medicamentos y protocolos para su tratamiento / Roy Patterson ... [et al.]Patterson, Roy; DeSwarte, Richard D; Greenberger, Paul A; Grammer, Leslie C-
2001Allocution du Directeur général au Conseil exécutif à sa cent septième session : Genève, lundi 15 janvier 2001Conseil exécutif, 107; Brundtland, Gro HarlemEB107/2; EB107/2 Corr.1
2002Alocución de la Directora General ante el Consejo Ejecutivo en su 109ª reunión: Ginebra, lunes 14 de enero de 2002Consejo Ejecutivo, 109; Brundtland, Gro HarlemEB109/2
2008Alocución de la Dra. Margaret Chan, Directora General, a la 61ª Asamblea Mundial de la SaludAsamblea Mundial de la Salud, 61; Chan, MargaretA61/3
1995Alternative drug pricing policies in the Americas / Alvaro Zerda SarmientoZerda Sarmiento, Alvaro; WHO Action Programme on Essential DrugsWHO/DAP/95.6. Unpublished
2007Amélioration des médicaments destinés aux enfantsAssemblée mondiale de la Santé, 60WHA60.20
2007Amélioration des médicaments destinés aux enfantsConseil exécutif, 120EB120.R13
2007Amélioration des médicaments destinés aux enfants : rapport du secrétariatAssemblée mondiale de la Santé, 60A60/25
2005Améliorer l’endiguement de la résistance aux antimicrobiensAssemblée mondiale de la Santé, 58WHA58.27
2005Antimicrobial resistance: a threat to global health securityExecutive Board 115EB115.R6
2005Antimicrobial resistance: a threat to global health security: rational use of medicines by prescribers and patients: report by the SecretariatWorld Health Assembly, 58A58/14
2004Antiretrovirals and developing countries : report by the SecretariatWorld Health Organization Executive Board Session. (115th : 2005: Geneva, Switzerland)EB115/32
Showing results 1 to 20 of 1158
 next >